Guided missiles

日期:2019-03-06 09:07:15 作者:甄怕筝 阅读:

By Sylvia Pagán Westphal LEANER appears to be meaner when it comes to anticancer drugs. A new slimline drug has caused complete remission in 11 out of 16 patients with one kind of leukaemia, say doctors in a US report. The drug, developed by Robert Kreitman’s team at the National Cancer Institute near Washington DC, is called BL22. It has been engineered so that one half is an antibody and the other is a bacterial toxin. Coupling an antibody with a bacterial toxin isn’t new in itself. Such “immunotoxins” have been used for over 10 years to treat some tumours,